TCM
LABD icon

Tradewinds Capital Management’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Tradewinds Capital Management’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-5
Closed -$69K – 677
2017
Q2 		$69K Buy
+5
New +$96.1K 0.04% 178
2016
Q4 		– Hold
0
– -$13K – 670
2016
Q3 		– Hold
0
– – – 347

Other funds holding LABD

Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
CT
CMT Trading Chicago, Illinois $22.4M AUM 78.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Tradewinds Capital Management's LABD Position: Q3 2017 in Review

Tradewinds Capital Management sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q3 2017, closing a stake of 5 shares — an estimated $69K sold.

Tradewinds Capital Management first reported a position in LABD in Q2 2017 and held it in 1 quarter. The position peaked at $69K in Q2 2017. 12 funds tracked by Wall St. Rank hold LABD as of Q3 2017.

  • Tradewinds Capital Management reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q3 2017 after selling out during the quarter.
  • Tradewinds Capital Management sold 5 Direxion Daily S&P Biotech Bear 3X ETF shares in Q3 2017, an estimated $69K.
  • Tradewinds Capital Management first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q2 2017 and held it in 1 quarter.
  • Tradewinds Capital Management's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $69K in Q2 2017.
  • 12 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q3 2017.

Based on Tradewinds Capital Management's 13F filing for Q3 2017, filed 3 Nov 2017.